Page 18 - B Cell News Today

In a new study, researchers evaluated SARS-CoV-2 vaccination-induced T cell responses cross-recognition among the early and novel SARS-CoV-2 variants.

Know everything about BENTA, the rare disease detected in a 7-month-old Bengaluru baby - Vijayadras is first BENTA case that has been identified at an early stage in terms of age & severity. He can be saved by a blood stem cell transplant

A recent study examined the question as to whether vaccination protects against Omicron infection by assessing breakthrough infection rates in participants at a superspreader event.

A recent preprint discusses using a combinatorial phage-display library approach to COVIID-19 antibodies.

Endometrial cancer is the most common cancer of the female reproductive system. Patients who have active immune responses against cancer cells tend to have better outcomes, but much of what is known focuses on only one type of immune cell called T cells.

The current study examines the role of heterologous vaccination, an area that lacks much clarity.

Researchers posted the results of a retrospective observational cohort study in which they determined the humoral and cellular responses in ISP to primary and booster doses of COVID-19 vaccines.

Memory B cells never forget recurrent viral exposures and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is no exception, according to a new medRxiv* preprint study.

Virus leaves antibodies that may attack healthy tissues; B cell antibodies weakened, not defeated by omicron

Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from researchers at Weill Cornell Medicine and Cornell's Ithaca campus.